30 Comments
Feb 4, 2022Liked by Katelyn Jetelina

Nice to see moths doing something other than putting holes in my knitting yearn. Nice reporting job....Bon chance to Tito's Vodka as well.

Sorry, just a retired Micrrobiologists humor. You are giving us wonderful information.

Expand full comment
Feb 4, 2022Liked by Katelyn Jetelina

What are the chances of these two being offered within the US? I know there are some that do not like the idea of the RNA vaccines. Also, think these would eventually make great boosters as they work on a different part of the immune system.

Expand full comment

Hotez and Botazzi are rock stars. Makes me wish I was still at the Texas Medical Center.

I've been anxiously awaiting both of these vaccines because they're safe, effective and don't have to employ a huge distribution infrastructure. We really can vaccinate the world. And, I applaud Dr Hotez's novel employment of a good Texas-originated vodka for funding. What most people don't appreciate is how much work goes into funding research and development and how little of it comes from the Feds.

I also especially like getting a bit more diversity in the classes of vaccines available. Perhaps (I know I'm stretching) using the Novavax technology will reduce some hesitancy among the skeptics.

Expand full comment
Feb 4, 2022Liked by Katelyn Jetelina

Thank you for reporting on this wonderful news. I appreciate your column very much.

Expand full comment

Relative to your opening comment, is there a concise explanation for why natural immunity is inadequate to achieve that goal? Consensus reports seem to be that Omicron is significantly less lethal then the 2020 virus, is now the dominant strain, has spread worldwide, and is profoundly communicable.

If true, doesn't the rapid spread of this highly communicable but mild virus, added to the now substantial pool of previously infected but recovered persons get us to international herd immunity sooner than vaccines? Also are we right in assuming that natural immunity is superior to vaccinated immunity in terms of protection against future variants?

Expand full comment

So important to report on. Thank you! And I appreciated the addition of the global map that shows how woefully behind the US is in vaccination rates compared to most of the world.

Expand full comment

Is there reason to hope that immunity from Novavax might last longer than from the mRNA vaccines? Thanks for all of your work!

Expand full comment

As you say, the mRNA vaccines are solutions for wealthy countries who can support the logistics of ultra cold storage.

The world needs alternatives, and these are promising. The challenge is, as you point out, that the Novavax trials were conducted with vaccines that were apparently not manufactured to FDA standards for purity and reproducibility between batches (there have been public statements citing CMC issues). The risk is that it is difficult to know whether the safety and efficacy data from different batches are comparable. I suspect this conundrum explains why there has been such a long delay between the conduct of the trials and the EUA. Very frustrating from everyone's perspective. Hopefully the path for sorting this all out is now established.

Expand full comment
founding

I would love to read your comments about Cuba's development of 5 different vaccines.

Expand full comment

Any update on the US military's vaccine development efforts?

Expand full comment
founding

Thanks so much for your reporting. Appreciate your perspectives (including as a mom) and your personal touch.

Expand full comment

Thanks for your very helpful updates, and this one is hopeful, too!

Expand full comment

We could sure use something new. Have you seen Israel's death rate?

Expand full comment

Love this! So exciting!

Expand full comment